Colorectal Cancer Trial, Recruiting NCT06633133 Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT06633133
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with rectal cancer, confirmed by a laboratory tissue test (pathology)
  • People who are 18 years of age or older
  • People who are having a specific type of rectal surgery that removes the rectum and reconnects the bowel — this includes procedures known as anterior resection, low anterior resection, intersphincteric resection, or transanal total mesorectal excision (confirm with trial site if unsure which applies)
  • People who are willing and able to sign a consent form agreeing to take part in the trial
  • People who are able to understand what the trial involves and what the potential risks are

Who may not be able to join:

  • People who need emergency surgery, or who are having open (non-keyhole) surgery
  • People whose overall health and surgical risk is rated above a certain level on a standard anaesthetic assessment scale (ASA score greater than 3) (confirm with trial site)
  • People who have a complete blockage of the bowel
  • People who have a long-term history of taking immune-suppressing medications or steroid medications (such as corticosteroids)
  • People with serious heart conditions, including heart failure, significantly reduced heart function, or those who have had a heart attack or heart bypass surgery within the past 6 months
  • People with severe kidney disease who require dialysis or have very low kidney function
  • People who need additional organs removed during the same operation
  • People who have cirrhosis (serious scarring) of the liver
  • People where the surgical join (anastomosis) is found during the operation to be incomplete or to not hold properly when tested
  • People having a specific two-stage bowel pull-through procedure (known as the Modified Bacon or Turnbull-Cutait procedure)
  • People where the surgeon decides during the operation that a temporary bowel diversion (ileostomy) is necessary due to an unexpected complication
  • People who are currently taking part in another clinical trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: fan li, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Phone: 18696539200

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Registry
ClinicalTrials.gov
Start date
10 October 2024
Est. completion
1 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Comprehensive Complication index (CCI) at the 6th postoperative month

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov